CD8A and lung carcinoma: Taken together, our results showed that the IRE+Combo is a promising, novel therapeutic protocol that combines IRE-ablation with immune adjuvant Combo to boost superior cDC1 and powerful CD8+ TRM cell responses against lung cancer.